COVID-19

Italy’s vaccine hopes: Italian firm IRBM group signs deal with Oxford University to develop vaccine

An Italian company that in the past joined the fight against Ebola has signed an agreement with Oxford University to develop a vaccine for coronavirus.
The Oxford-AstraZeneca vaccine is one of 150 in development globally, but is considered the most advanced.
First trial results suggest that the vaccine produces a good immune response in volunteers without serious side-effects.
Euronews spoke to the Managing Director of the Italian company that worked on the project. Giorgia Orlandi reports.

Categories: COVID-19

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s